GRANULES - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.8
| Stock Code | GRANULES | Market Cap | 17,338 Cr. | Current Price | 700 ₹ | High / Low | 731 ₹ |
| Stock P/E | 42.3 | Book Value | 178 ₹ | Dividend Yield | 0.21 % | ROCE | 12.8 % |
| ROE | 10.5 % | Face Value | 1.00 ₹ | DMA 50 | 629 ₹ | DMA 200 | 575 ₹ |
| Chg in FII Hold | 1.76 % | Chg in DII Hold | -0.46 % | PAT Qtr | 99.0 Cr. | PAT Prev Qtr | 112 Cr. |
| RSI | 73.1 | MACD | 25.8 | Volume | 18,27,818 | Avg Vol 1Wk | 27,21,229 |
| Low price | 431 ₹ | High price | 731 ₹ | PEG Ratio | -6.60 | Debt to equity | 0.19 |
| 52w Index | 89.6 % | Qtr Profit Var | 36.1 % | EPS | 16.2 ₹ | Industry PE | 30.1 |
📈 Chart & Trend: GRANULES is trading well above its 50 DMA (629 ₹) and 200 DMA (575 ₹), confirming strong bullish momentum. RSI at 73.1 indicates overbought conditions, while MACD at 25.8 remains positive, supporting upward bias. Bollinger Bands show price near the upper band, suggesting resistance and potential profit booking.
🔎 Momentum Signals: Current volume (18.3 lakh) is below the 1-week average (27.2 lakh), reflecting reduced participation. Momentum remains strong but stretched, with risk of consolidation.
🎯 Entry Zone: 620–640 ₹ (support near 50 DMA)
🚪 Exit Zone: 720–730 ₹ (resistance near 52-week high)
📊 Trend Status: Trending upward but overbought; consolidation likely.
Positive
- Strong trading momentum supported by price above both DMAs.
- FII holdings increased (+1.76%), showing foreign investor confidence.
- Quarterly profit variation (+36.1%) highlights earnings strength.
- Low debt-to-equity (0.19) ensures financial stability.
Limitation
- High P/E (42.3) compared to industry average (30.1), indicating overvaluation.
- ROCE (12.8%) and ROE (10.5%) are modest, limiting efficiency appeal.
- PEG ratio (-6.60) signals weak growth prospects relative to valuation.
- Dividend yield at 0.21% offers negligible income support.
Company Negative News
- Sequential decline in quarterly PAT (112 Cr. → 99 Cr.).
- DII holdings decreased (-0.46%), showing reduced domestic support.
Company Positive News
- Strong momentum with RSI and MACD confirming bullish bias.
- FII inflows highlight foreign investor confidence.
Industry
- Industry P/E at 30.1 reflects moderate valuations across pharma sector.
- Sector supported by steady demand for generics and specialty pharma products.
Conclusion
GRANULES is in a strong uptrend but overbought, with limited upside near its 52-week high. Entry near 620–640 ₹ offers better risk-reward, while profit booking is advised near 720–730 ₹. Short-term consolidation is likely, while long-term outlook depends on sustaining earnings growth and improving efficiency metrics.
This modular HTML report is aligned with your workflow. Would you like me to extend this into a swing vs. investment horizon overlay so you can see how GRANULES behaves across different trading strategies?